A novel next-generation FVIIIa mimetic, Mim8, has a favorable safety profile and displays potent pharmacodynamic effects: results from safety studies in cynomolgus monkeys - Lauritzen, B; Bjelke, M; Björkdahl, O (J Thromb Haemost, 2022)